Skip to main content
Signal8
Gavel Steve profile photo

Steve Gavel

CIK: 0002090785

Transaction Breakdown

Open Market Buys (P)1 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Cabaletta Bio, Inc. logo
CABA

Cabaletta Bio, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Cabaletta Bio, Inc. logo
    CABA

    Cabaletta Bio, Inc.

    Jan 21, 2026
    Purchase(P)
    Direct
    22.2K shares at avg. $2.27$50K
  • Cabaletta Bio, Inc. logo
    CABA

    Cabaletta Bio, Inc.

    Oct 13, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    275K shares-

1-2 of 2

About Gavel Steve

Gavel Steve (SEC CIK 0002090785) files insider reports with the SEC as Chief Commercial Officer of Cabaletta Bio, Inc. (CABA).

Signal8 holds 3 ownership filings by Gavel Steve (1 Form 3, 2 Form 4), filed between Oct 15, 2025 and Jan 21, 2026. Those filings report 2 transactions, from Oct 13, 2025 to Jan 21, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Gavel Steve's filings is in PHILADELPHIA, PA.

Recent filings by Gavel Steve

  • Jan 21, 2026: Open-market purchase of CABA shares (Form 4, code P).
  • Oct 13, 2025: Grant or award of CABA derivative securities (Form 4, code A).

Other insiders filing for Cabaletta Bio, Inc. (CABA)

How to read Form 4 transaction codes